HEADER ANTITUMOR 17-JUL-01 1JM7 TITLE SOLUTION STRUCTURE OF THE BRCA1/BARD1 RING-DOMAIN TITLE 2 HETERODIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RING-DOMAIN; COMPND 5 SYNONYM: BRCA1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: RESIDUES 104-112 OF CHAIN A AND 123-142 OF COMPND 8 CHAIN B ARE MISSING IN EACH MODEL DUE TO DISORDER.; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BRCA1-ASSOCIATED RING DOMAIN PROTEIN 1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RING-DOMAIN; COMPND 13 SYNONYM: BARD1; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRCA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLAMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BARD1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS BRCA1, BARD1, RING FINGER, ZINC-BINDING PROTEIN, KEYWDS 2 HETERODIMER, UBIQUITIN LIGASE, ANTITUMOR EXPDTA SOLUTION NMR NUMMDL 14 AUTHOR P.S.BRZOVIC,P.RAJAGOPAL,D.W.HOYT,M.-C.KING,R.E.KLEVIT REVDAT 3 24-FEB-09 1JM7 1 VERSN REVDAT 2 01-APR-03 1JM7 1 JRNL REVDAT 1 03-OCT-01 1JM7 0 JRNL AUTH P.S.BRZOVIC,P.RAJAGOPAL,D.W.HOYT,M.C.KING, JRNL AUTH 2 R.E.KLEVIT JRNL TITL STRUCTURE OF A BRCA1-BARD1 HETERODIMERIC RING-RING JRNL TITL 2 COMPLEX. JRNL REF NAT.STRUCT.BIOL. V. 8 833 2001 JRNL REFN ISSN 1072-8368 JRNL PMID 11573085 JRNL DOI 10.1038/NSB1001-833 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 1664 RESTRAINTS, 480 INTRARESIDUE RESTRAINTS, 475 SEQUENTIAL REMARK 3 RESTRAINTS, 215 MEDIUM-RANGE RESTRAINTS, 256 LONG-RANGE REMARK 3 RESTRAINTS, 82 INTERMOLECULAR RESTRAINTS, 70 HYDROGEN BOND REMARK 3 RESTRAINTS, 16 ZINC RESTRAINTS REMARK 4 REMARK 4 1JM7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JUL-01. REMARK 100 THE RCSB ID CODE IS RCSB013931. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 315; 315; 315; 315 REMARK 210 PH : 6.8; 6.8; 6.8; 6.8 REMARK 210 IONIC STRENGTH : 0.2M NACL; 0.2M NACL; 0.2M REMARK 210 NACL; 0.2M NACL REMARK 210 PRESSURE : AMBIENT; AMBIENT; AMBIENT; REMARK 210 AMBIENT REMARK 210 SAMPLE CONTENTS : SAMPLE 1: 0.8-1.1MM U-15N,13C REMARK 210 BRCA1; UNLABELED BARD1, 25MM REMARK 210 SODIUM PHOSPHATE, 0.2M NACL, REMARK 210 2MM DTT. SAMPLE 2: 0.8-1.1MM U REMARK 210 -15N,13C BARD1; UNLABELED REMARK 210 BRCA1, 25MM SODIUM PHOSPHATE, REMARK 210 0.2M NACL, 2MM DTT. SAMPLE 3: REMARK 210 0.8-1.1MM U-15N,13C,85%-2H REMARK 210 BRCA1; UNLABELED BARD1, 25MM REMARK 210 SODIUM PHOSPHATE, 0.2M NACL, REMARK 210 2MM DTT. SAMPLE 4: 0.8-1.1MM U REMARK 210 -15N,13C,85%-2H BARD1; REMARK 210 UNLABELED BRCA,1 25MM SODIUM REMARK 210 PHOSPHATE, 0.2M NACL, 2MM REMARK 210 DTT.; 0.8-1.1MM U-15N,13C REMARK 210 BARD1; UNLABELED BRCA1 25MM REMARK 210 SODIUM PHOSPHATE 0.2M NACL 2MM REMARK 210 DTT; 0.8-1.1MM U-15N,13C,85%- REMARK 210 2H BRCA1; UNLABELED BARD1 25MM REMARK 210 SODIUM PHOSPHATE 0.2M NACL 2MM REMARK 210 DTT; 0.8-1.1MM U-15N,13C,85%- REMARK 210 2H BARD1; UNLABELED BRCA1 25MM REMARK 210 SODIUM PHOSPHATE 0.2M NACL 2MM REMARK 210 DTT REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY, 4D_ REMARK 210 13C-SEPARATED_NOESY, 3D_15N/ REMARK 210 13C-SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ, 600 MHZ, 800 MHZ REMARK 210 SPECTROMETER MODEL : DMX, INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER, VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 2.6, VNMR, NMRPIPE, REMARK 210 NMRVIEW 5.0, CNS 1.0 REMARK 210 METHOD USED : DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 25 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 14 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, REMARK 210 STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 2 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 1 ZN A 123 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 24 SG REMARK 620 2 CYS A 44 SG 88.2 REMARK 620 3 CYS A 47 SG 123.2 88.2 REMARK 620 4 CYS A 27 SG 86.9 138.2 128.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 1 ZN A 124 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 39 SG REMARK 620 2 CYS A 64 SG 89.1 REMARK 620 3 HIS A 41 NE2 106.7 149.0 REMARK 620 4 CYS A 61 SG 109.0 89.0 109.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 1 ZN B 143 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 50 SG REMARK 620 2 CYS B 71 SG 88.1 REMARK 620 3 CYS B 74 SG 161.6 102.5 REMARK 620 4 CYS B 53 SG 107.4 88.6 88.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 1 ZN B 144 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 83 SG REMARK 620 2 CYS B 86 SG 131.2 REMARK 620 3 CYS B 66 SG 128.2 93.2 REMARK 620 4 HIS B 68 ND1 90.1 73.9 132.7 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 123 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 124 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 143 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 144 DBREF 1JM7 A 1 110 UNP P38398 BRCA1_HUMAN 1 110 DBREF 1JM7 B 26 140 UNP Q99728 BARD1_HUMAN 26 140 SEQADV 1JM7 GLY A 111 UNP P38398 CLONING ARTIFACT SEQADV 1JM7 LYS A 112 UNP P38398 CLONING ARTIFACT SEQADV 1JM7 GLY B 141 UNP Q99728 CLONING ARTIFACT SEQADV 1JM7 LYS B 142 UNP Q99728 CLONING ARTIFACT SEQRES 1 A 112 MET ASP LEU SER ALA LEU ARG VAL GLU GLU VAL GLN ASN SEQRES 2 A 112 VAL ILE ASN ALA MET GLN LYS ILE LEU GLU CYS PRO ILE SEQRES 3 A 112 CYS LEU GLU LEU ILE LYS GLU PRO VAL SER THR LYS CYS SEQRES 4 A 112 ASP HIS ILE PHE CYS LYS PHE CYS MET LEU LYS LEU LEU SEQRES 5 A 112 ASN GLN LYS LYS GLY PRO SER GLN CYS PRO LEU CYS LYS SEQRES 6 A 112 ASN ASP ILE THR LYS ARG SER LEU GLN GLU SER THR ARG SEQRES 7 A 112 PHE SER GLN LEU VAL GLU GLU LEU LEU LYS ILE ILE CYS SEQRES 8 A 112 ALA PHE GLN LEU ASP THR GLY LEU GLU TYR ALA ASN SER SEQRES 9 A 112 TYR ASN PHE ALA LYS LYS GLY LYS SEQRES 1 B 117 MET GLU PRO ASP GLY ARG GLY ALA TRP ALA HIS SER ARG SEQRES 2 B 117 ALA ALA LEU ASP ARG LEU GLU LYS LEU LEU ARG CYS SER SEQRES 3 B 117 ARG CYS THR ASN ILE LEU ARG GLU PRO VAL CYS LEU GLY SEQRES 4 B 117 GLY CYS GLU HIS ILE PHE CYS SER ASN CYS VAL SER ASP SEQRES 5 B 117 CYS ILE GLY THR GLY CYS PRO VAL CYS TYR THR PRO ALA SEQRES 6 B 117 TRP ILE GLN ASP LEU LYS ILE ASN ARG GLN LEU ASP SER SEQRES 7 B 117 MET ILE GLN LEU CYS SER LYS LEU ARG ASN LEU LEU HIS SEQRES 8 B 117 ASP ASN GLU LEU SER ASP LEU LYS GLU ASP LYS PRO ARG SEQRES 9 B 117 LYS SER LEU PHE ASN ASP ALA GLY ASN LYS LYS GLY LYS HET ZN A 123 1 HET ZN A 124 1 HET ZN B 143 1 HET ZN B 144 1 HETNAM ZN ZINC ION FORMUL 3 ZN 4(ZN 2+) HELIX 1 1 ARG A 7 LEU A 22 1 16 HELIX 2 2 LYS A 45 GLN A 54 1 10 HELIX 3 3 SER A 80 THR A 97 1 18 HELIX 4 4 TRP B 34 LEU B 47 1 14 HELIX 5 5 CYS B 74 ILE B 79 5 6 HELIX 6 6 ASN B 98 ASP B 117 1 20 SHEET 1 A 1 VAL A 35 SER A 36 0 SHEET 1 B 1 ILE A 42 PHE A 43 0 SHEET 1 C 1 GLN A 74 GLU A 75 0 SHEET 1 D 1 VAL B 61 CYS B 62 0 SHEET 1 E 1 ILE B 69 PHE B 70 0 LINK ZN ZN A 123 SG CYS A 24 1555 1555 2.41 LINK ZN ZN A 123 SG CYS A 44 1555 1555 2.41 LINK ZN ZN A 123 SG CYS A 47 1555 1555 2.41 LINK ZN ZN A 123 SG CYS A 27 1555 1555 2.42 LINK ZN ZN A 124 SG CYS A 39 1555 1555 2.39 LINK ZN ZN A 124 SG CYS A 64 1555 1555 2.40 LINK ZN ZN A 124 NE2 HIS A 41 1555 1555 2.45 LINK ZN ZN A 124 SG CYS A 61 1555 1555 2.40 LINK ZN ZN B 143 SG CYS B 50 1555 1555 2.42 LINK ZN ZN B 143 SG CYS B 71 1555 1555 2.40 LINK ZN ZN B 143 SG CYS B 74 1555 1555 2.42 LINK ZN ZN B 143 SG CYS B 53 1555 1555 2.41 LINK ZN ZN B 144 SG CYS B 83 1555 1555 2.42 LINK ZN ZN B 144 SG CYS B 86 1555 1555 2.42 LINK ZN ZN B 144 SG CYS B 66 1555 1555 2.42 LINK ZN ZN B 144 ND1 HIS B 68 1555 1555 2.61 SITE 1 AC1 5 CYS A 24 ILE A 26 CYS A 27 CYS A 44 SITE 2 AC1 5 CYS A 47 SITE 1 AC2 4 CYS A 39 HIS A 41 CYS A 61 CYS A 64 SITE 1 AC3 4 CYS B 50 CYS B 53 CYS B 71 CYS B 74 SITE 1 AC4 4 CYS B 66 HIS B 68 CYS B 83 CYS B 86 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1